I

n the moments after a spinal cord injury, a process of degradation begins throughout the body, swiftly killing motor function and a patient’s quality of life.

Vinod Labhasetwar is using nanotechnology to try to stop that process in its tracks, injecting tiny particles containing antioxidant enzymes into patients to limit the damage from their injuries and, he hopes, preserve critical movement.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.